Global Antimicrobial Susceptibility Testing Market 2019-2023| Evolving Opportunities with bioMérieux SA and Bio-Rad Laboratories Inc. | Technavio
November 21, 2019LONDON–(BUSINESS WIRE)–#Biotechnology–Technavio has been monitoring the global antimicrobial susceptibility testing market and the market is poised to grow by USD 832.14 million during 2019-2023 at a CAGR of over 5% during the forecast period. Request Free Sample Pages
Read the 124-page research report with TOC on “Antimicrobial Susceptibility Testing Market Analysis Report by Application (Clinical diagnostics, Drug discovery and development, and Others), by Geography (Asia, Europe, North America, and ROW), and Segment Forecasts, 2019 – 2023.“
The market is driven by the increasing government initiatives to increase awareness about the treatment of infections caused by pathogens. In addition, the increase in collaborations between government and private stakeholders is anticipated to further boost the growth of the antimicrobial susceptibility testing market.
Factors such as the growing population base and increasing consumption of medicines is driving the sales of antibiotics. This is leading to one of the major health problems, i.e. microbial resistance (AR) to antibiotics, especially in the emerging countries. As a result, governments are introducing various programs to create an awareness about the effects of drugs on pathogens. This is driving the demand for antimicrobial susceptibility testing (AST), as it helps in determining the type of bacteria or fungi that develops resistance against antibiotics and antifungal drugs. Thus, the increasing government initiatives are expected to drive market growth during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing
Major Five Antimicrobial Susceptibility Testing Market Companies:
bioMérieux SA
bioMérieux SA is headquartered in France and operates under the business segment, In vitro diagnostics. The company offers test strips, ETEST that can be used to determine on-scale minimum inhibitory concentration (MIC) of antibiotics.
Bio-Rad Laboratories Inc.
Bio-Rad Laboratories Inc. is headquartered in the US and offers products through the following business units: Life Science and Clinical Diagnostics. The company offers an AST system, ADAGIO that complies with CLSI or EUCAST guidelines.
Danaher Corp.
IBM Corp. is headquartered in the US and operates under various business segments, namely Life sciences, Diagnostics, Dental, and Environmental & Applied Solutions. The company offers MicroScan WalkAway plus System, which is ideal for mid to high-volume usage.
Merck KGaA
Merck KGaA is headquartered in Germany and offers products through the following business segments: Healthcare, Life Science, and Performance Materials. The company offers Antimicrobial Susceptibility Disks, which is used for the determination of antimicrobial susceptibility.
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is headquartered in the US and offers products through the following business segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The company offers a complete automated system, Sensititre Complete Automated AST System.
Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio’s SUBSCRIPTION platform
Antimicrobial Susceptibility Testing Application Outlook (Revenue, USD Million, 2019 – 2023)
- Clinical Diagnostics
- Drug discovery and development
- Others
Antimicrobial Susceptibility Testing Regional Outlook (Revenue, USD Million, 2019 – 2023)
- Asia
- Europe
- North America
- ROW
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
Related Reports on Health Care are:
Antimicrobial Therapeutics Market – Global Antimicrobial Therapeutics Market by application (antiviral, antibacterial, antifungal, and antiparasitic) and geography (Asia, Europe, North America, and ROW).
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: https://www.technavio.com/